Lingdancao Granules in the Treatment of Seasonal Influenza
Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
Name of study:
Randomized, Double-Blinded, Oseltamivir-and-Placebo-Controlled Clinical Study about
Lingdancao Granules in the Treatment of Seasonal Influenza
Objective:
Preliminary evaluation on the efficacy and safety of Lingdancao granules in the treatment of
seasonal influenza
Design:
Multicenter, randomized, double-blind, double parallel analogy, positive drug and placebo
controlled trial
Case number:
This test is expected to be included in 318 cases of 14-65 (≥14 or ≤65) ages of subjects.
Qualified participants are randomly divided into experimental drug group (Lingdancao granules
group), positive control group (oseltamivir phosphate group) and placebo group, 106 cases in
each.
Phase:
Phase 3
Details
Lead Sponsor:
The First Affiliated Hospital of Guangzhou Medical University